Clinical Outcomes of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy

The optimal doses of ceftazidime-avibactam (CZA) and ceftolozane-tazobactam (C/T) for treating multidrug-resistant (MDR) Pseudomonas aeruginosa (PSA) in patients utilizing renal replacement therapy (RRT) are not well established. Hence, the objective of this study is to evaluate the clinical outcome...

Full description

Saved in:
Bibliographic Details
Main Authors: Wasim S. El Nekidy (Author), Mooza Al Ali (Author), Emna Abidi (Author), Rania El Lababidi (Author), Diaa Alrahmany (Author), Islam M. Ghazi (Author), Mohamad Mooty (Author), Fadi Hijazi (Author), Muriel Ghosn (Author), Jihad Mallat (Author)
Format: Book
Published: MDPI AG, 2024-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available